Research programme: peptide mimics - Mimetica

Drug Profile

Research programme: peptide mimics - Mimetica

Alternative Names: GPCR mimetics - Mimetica; Peptide mimetic scaffolds - Mimetica; Peptide mimetics - Mimetica

Latest Information Update: 31 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mimetica
  • Class Peptides; Small molecules
  • Mechanism of Action G protein-coupled receptor modulators; Melanocortin receptor antagonists; Peptide receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Cancer; Inflammation; Obesity; Skin disorders

Most Recent Events

  • 31 Dec 2015 No recent reports on development identified - Preclinical for Skin disorders in Australia (unspecified route)
  • 07 Feb 2011 Preclinical development for Skin disorders is ongoing (Australia)
  • 07 Feb 2011 No development reported - Preclinical for Cancer in Australia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top